Literature DB >> 27138912

The evidence base of methylphenidate for children and adolescents with attention-deficit hyperactivity disorder is in fact flawed.

Ole Jakob Storebø1,2,3, Erik Simonsen4,5, Christian Gluud6,7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27138912     DOI： 10.1007/s00787-016-0855-0

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN： 1018-8827            Impact factor:   4.785


× No keyword cloud information.
  9 in total

1.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study.

Authors:  Lesley Wood; Matthias Egger; Lise Lotte Gluud; Kenneth F Schulz; Peter Jüni; Douglas G Altman; Christian Gluud; Richard M Martin; Anthony J G Wood; Jonathan A C Sterne
Journal:  BMJ       Date:  2008-03-03

2.  Nocebo in clinical trials for depression: a meta-analysis.

Authors:  Dimos D Mitsikostas; Leonidas Mantonakis; Nikolaos Chalarakis
Journal:  Psychiatry Res       Date:  2013-10-25       Impact factor: 3.222

Review 3.  Industry sponsorship and research outcome.

Authors:  Andreas Lundh; Sergio Sismondo; Joel Lexchin; Octavian A Busuioc; Lisa Bero
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

4.  Why the Cochrane risk of bias tool should include funding source as a standard item.

Authors:  Lisa A Bero
Journal:  Cochrane Database Syst Rev       Date:  2013-12-20

5.  Is the evidence base of methylphenidate for children and adolescents with attention-deficit/hyperactivity disorder flawed?

Authors:  Pieter J Hoekstra; Jan K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-04       Impact factor: 4.785

Review 6.  Placebo and nocebo effect: a mini-review.

Authors:  Ivan Požgain; Zrinka Požgain; Dunja Degmečić
Journal:  Psychiatr Danub       Date:  2014-06       Impact factor: 1.063

Review 7.  Active placebos versus antidepressants for depression.

Authors:  J Moncrieff; S Wessely; R Hardy
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials.

Authors:  Jelena Savović; Hayley E Jones; Douglas G Altman; Ross J Harris; Peter Jüni; Julie Pildal; Bodil Als-Nielsen; Ethan M Balk; Christian Gluud; Lise Lotte Gluud; John P A Ioannidis; Kenneth F Schulz; Rebecca Beynon; Nicky J Welton; Lesley Wood; David Moher; Jonathan J Deeks; Jonathan A C Sterne
Journal:  Ann Intern Med       Date:  2012-09-18       Impact factor: 25.391

Review 9.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  9 in total
  3 in total

1.  Child and adolescent psychiatry in ICD-11: an opportunity to overcome mistakes made in DSM-5?

Authors:  Veit Roessner; Stefan Ehrlich; Nora C Vetter
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09       Impact factor: 4.785

2.  The Cochrane Collaboration withdraws a review on methylphenidate for adults with attention deficit hyperactivity disorder.

Authors:  Kim Boesen; Luis Carlos Saiz; Juan Erviti; Ole Jakob Storebø; Christian Gluud; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Evid Based Med       Date:  2017-07-13

3.  Prevalence and comorbidity of attention deficit hyperactivity disorder in Spain: study protocol for extending a systematic review with updated meta-analysis of observational studies.

Authors:  Ferrán Catalá-López; Manuel Ridao; Amparo Núñez-Beltrán; Ricard Gènova-Maleras; Adolfo Alonso-Arroyo; Rafael Aleixandre-Benavent; Miguel A Catalá; Rafael Tabarés-Seisdedos
Journal:  Syst Rev       Date:  2019-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.